Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
29
self-reported 11–50 band
Founded
2012
14 years
Legal entities
1
ACRA
Office countries
1
1 address
Funding rounds
None on record
Company type
Privately Held
self-reported
Legal entity
1 brand → 1 confirmed entity
INVITROCUE PTE. LTD.Entity record →
UEN201224616W
Legal entities
Show as table · Invitrocue: 1 registry entity
| INVITROCUE PTE. LTD. | UEN 201224616W |
|---|---|
| Confirmed matches | 1 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Description
An innovative life sciences company that specialises in developing ground-breaking 3D cell-based models such as Patient-Derived Organoids from all solid cancers.
By utilizing Onco-PDO test, we perform in vitro drug screenings on PDOs to provide the oncologists with the information to better direct patient therapy and personalized patient treatment.
By enabling assessments of the best ways for drugs to be developed, we impart to the industry valuable knowledge in creating better, faster and more affordable disease treatments, working towards the company’s goal of creating a healthier society by providing patients with the best possible care.
Headquartered in Singapore and with operations in Australia, China, Hong Kong and Germany, Invitrocue’s Onco-PDO technology enables patient-derived cancer cells (organoids) to be cultured in laboratories for testing against a panel of drugs to support personalised clinical decisions.
By enabling assessments of the best ways for drugs to be developed, Invitrocue creates better, faster and more affordable disease treatments, that work towards the company’s goal of creating a healthier society by providing patients with the best possible care.
To learn more please visit: https://www.invitrocue.com
Specialties
All 7 specialties
- Contract Research Organization
- ONCO-PDO Test
- Personalized Oncology
- PDO-derived Xenograft
- Pharmacology Services
- Safety Assessment
- Patient-derived Organoids
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | US |
All codes: US
Addresses
- US51 Science Park Rd,; #01-11/13 The Aries, Singapore Science Park II,; Singapore , Singapore 117586Primary
Grid intelligence Members
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Names are withheld until a consented source exists.
FAQ
Which legal entity operates under Invitrocue?
One Singapore entity on ACRA: INVITROCUE PTE. LTD. (UEN 201224616W), high confidence.
How many people work at Invitrocue?
29 counted staff profiles at January 2026, inside the self-reported 11–50 band.
Where does Invitrocue have offices?
One address on record, Singapore only. Primary: 51 Science Park Rd, #01-11/13 The Aries, Singapore Science Park II, Singapore 117586.
Has Invitrocue raised funding?
None linked to this brand.
What does Invitrocue list as its specialties?
Seven tags on the brand's own list, among them Contract Research Organization, ONCO-PDO Test and Personalized Oncology.
Which companies are listed alongside Invitrocue?
11 profiles list Invitrocue as a peer — 84th percentile in Biotechnology Research. It lists ten peers of its own. Invivocue and Ants Innovate list it back.